Alpine Immune Sciences (ALPN) Short Interest Ratio & Short Volume → Who are Nvidia’s New Silent Partners? (From Weiss Ratings) (Ad) Free ALPN Stock Alerts $64.97 +0.01 (+0.02%) (As of 05/20/2024) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Alpine Immune Sciences Short Interest DataCurrent Short Interest3,890,000 sharesPrevious Short Interest4,740,000 sharesChange Vs. Previous Month-17.93%Dollar Volume Sold Short$251.26 millionShort Interest Ratio1.7 Days to CoverLast Record DateApril 30, 2024Outstanding Shares68,598,000 sharesPercentage of Shares Shorted5.67%Today's Trading Volume4,288,300 sharesAverage Trading Volume1,917,072 sharesToday's Volume Vs. Average224% Short Selling Alpine Immune Sciences ? Sign up to receive the latest short interest report for Alpine Immune Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartALPN Short Interest Over TimeALPN Days to Cover Over TimeALPN Percentage of Float Shorted Over Time Ad Crypto 101 MediaThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.Click here for all the details… Alpine Immune Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20243,890,000 shares $251.26 million -17.9%N/A1.7 $64.59 4/15/20244,740,000 shares $305.35 million -10.2%N/A2.1 $64.42 3/31/20245,280,000 shares $209.30 million -5.9%N/A4.4 $39.64 3/15/20245,610,000 shares $204.09 million +26.6%N/A5.1 $36.38 2/29/20244,430,000 shares $156.02 million +9.9%N/A4.4 $35.22 2/15/20244,030,000 shares $120.42 million +20.7%N/A4.3 $29.88 Get the Latest News and Ratings for ALPN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alpine Immune Sciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/20243,340,000 shares $88.88 million +38.6%N/A3.6 $26.61 1/15/20242,410,000 shares $49.28 million -39.5%N/A3.1 $20.45 12/31/20233,980,000 shares $75.86 million +32.7%N/A5 $19.06 12/15/20233,000,000 shares $56.70 million -9.6%N/A4 $18.90 11/30/20233,320,000 shares $51.46 million -23.7%N/A5.1 $15.50 11/15/20234,350,000 shares $54.94 million +51.0%N/A7.5 $12.63 10/31/20232,880,000 shares $29.49 million +31.5%N/A5.6 $10.24 10/15/20232,190,000 shares $22.47 million -21.8%N/A6.8 $10.26 9/30/20232,800,000 shares $32.06 million +6.9%N/A11 $11.45 9/15/20232,620,000 shares $32.93 million +4.0%N/A11.3 $12.57 8/31/20232,520,000 shares $31.12 million +28.6%N/A10.8 $12.35 8/15/20231,960,000 shares $26.46 million +31.5%N/A8.9 $13.50 7/31/20231,490,000 shares $18.68 million +0.7%N/A6.5 $12.54 7/15/20231,480,000 shares $16.32 million -3.3%N/A7.8 $11.03 6/30/20231,530,000 shares $15.73 million +26.5%N/A8.9 $10.28 6/15/20231,210,000 shares $13.19 million +1.7%N/A7.2 $10.90 5/31/20231,190,000 shares $11.85 million +3.5%N/A10.3 $9.96 5/15/20231,150,000 shares $9.97 million +8.5%N/A10.7 $8.67 4/30/20231,060,000 shares $7.94 million +1.9%N/A14.8 $7.49 4/15/20231,040,000 shares $7.60 million -1.0%N/A13.3 $7.31 3/31/20231,050,000 shares $8.11 million +17.6%N/A12.5 $7.72 3/15/2023892,900 shares $7.18 million +10.8%N/A9.7 $8.04 2/28/2023805,900 shares $6.42 million +8.7%N/A7.5 $7.97 2/15/2023741,100 shares $6.24 million -2.8%N/A6.7 $8.42 1/31/2023762,700 shares $6.41 million -6.6%N/A6.7 $8.40 1/15/2023816,200 shares $7.14 million -65.0%N/A6.6 $8.75 12/30/20222,330,000 shares $17.13 million -0.4%N/A19 $7.35 12/15/20222,340,000 shares $15.28 million +6.4%N/A18.4 $6.53 11/30/20222,200,000 shares $13.82 million +4.3%N/A19.4 $6.28 11/15/20222,110,000 shares $13.19 million +11.6%N/A19.4 $6.25 10/31/20221,890,000 shares $11.17 million +2.7%N/A19.5 $5.91 10/15/20221,840,000 shares $13.06 million +12.9%N/A20.2 $7.10 9/30/20221,630,000 shares $11.74 million +19.0%N/A20.7 $7.20 9/15/20221,370,000 shares $11.10 million -2.1%7.0%17.6 $8.10Trump’s Gift Could Unleash $51 Billion in New Wealth (Ad)In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. 8/31/20221,400,000 shares $10.51 million No Change10.4%20.8 $7.51 8/15/20221,400,000 shares $12.15 million +0.7%10.4%16.5 $8.68 7/31/20221,390,000 shares $11.05 million -0.7%11.4%14.7 $7.95 7/15/20221,400,000 shares $12.60 million +0.7%11.4%14.4 $9.00 6/30/20221,390,000 shares $11.83 million -6.1%11.3%12.8 $8.51 6/15/20221,480,000 shares $12.71 million +4.2%12.1%12.6 $8.59 5/31/20221,420,000 shares $13.21 million No Change11.6%13.3 $9.30 5/15/20221,420,000 shares $10.72 million -0.7%11.6%13.4 $7.55 4/30/20221,430,000 shares $13.16 million +7.5%10.2%12.1 $9.20 4/15/20221,330,000 shares $10.64 million -2.2%9.5%11.2 $8.00 3/31/20221,360,000 shares $12.20 million -2.2%9.7%11.3 $8.97 3/15/20221,390,000 shares $10.65 million +1.5%10.3%10.5 $7.66 2/28/20221,370,000 shares $11.29 million +21.2%10.2%10.4 $8.24 2/15/20221,130,000 shares $8.99 million +4.6%8.4%8.9 $7.96 1/31/20221,080,000 shares $9.18 million +1.9%8.0%10.3 $8.50 1/15/20221,060,000 shares $11.03 million +3.9%7.8%10.2 $10.41 12/31/20211,020,000 shares $14.13 million +118.0%7.5%10.9 $13.85 12/15/2021467,800 shares $5.86 million +23.9%3.5%4.8 $12.53 11/30/2021377,700 shares $4.09 million -7.2%2.8%4.3 $10.83 11/15/2021407,200 shares $5.39 million +2.0%3.0%4.4 $13.24 10/29/2021399,100 shares $5.05 million -4.4%4.4%4.9 $12.65 10/15/2021417,600 shares $4.75 million -11.9%4.6%5.1 $11.38 9/30/2021474,200 shares $5.06 million -27.6%5.2%5.3 $10.67 9/15/2021654,800 shares $6.42 million -14.7%6.4%6.2 $9.81 8/31/2021767,400 shares $7.30 million -4.4%7.6%7.2 $9.51 8/13/2021802,300 shares $7.42 million +1.9%8.1%6.7 $9.25 7/30/2021787,100 shares $6.96 million +1.7%7.9%5.8 $8.84 7/15/2021774,200 shares $6.46 million -9.0%6.0%5.6 $8.35 6/30/2021850,700 shares $7.66 million +47.0%6.5%6.3 $9.00 6/15/2021578,700 shares $5.38 million -6.2%4.5%5.4 $9.29 5/28/2021616,800 shares $6.58 million -2.2%4.8%6 $10.66 5/14/2021630,700 shares $7.24 million +0.6%6.4%5.7 $11.48 4/30/2021626,700 shares $8.05 million +4.2%4.6%5.8 $12.84 4/15/2021601,700 shares $6.78 million -6.6%4.4%5.1 $11.26 3/31/2021644,300 shares $6.55 million +17.6%3.9%5.1 $10.17 3/15/2021548,000 shares $7.30 million +42.2%4.3%3.9 $13.33 2/26/2021385,500 shares $4.40 million +2.2%3.0%2.6 $11.41 2/12/2021377,200 shares $4.91 million +20.9%3.0%2.9 $13.03 1/29/2021311,900 shares $3.68 million -1.7%2.5%2.7 $11.81 1/15/2021317,400 shares $4.41 million +502.3%2.5%3.3 $13.89 12/31/202052,700 shares $661,912.00 +86.9%0.4%0.7 $12.56 12/15/202028,200 shares $377,880.00 +4.8%0.2%0.4 $13.40 11/30/202026,900 shares $264,696.00 +5.5%0.2%0.6 $9.84 11/15/202025,500 shares $208,590.00 -22.5%0.2%0.6 $8.18 10/30/202032,900 shares $252,672.00 +29.5%0.3%0.7 $7.68 10/15/202025,400 shares $217,170.00 -5.2%0.2%0.4 $8.55 9/30/202026,800 shares $235,572.00 +230.9%0.2%0.4 $8.79 9/15/20208,100 shares $67,068.00 +14.1%0.1%0.1 $8.28 8/31/20207,100 shares $57,936.00 -62.8%0.1%0 $8.16 8/14/202019,100 shares $179,731.00 +27.3%0.2%0 $9.41Trump’s Gift Could Unleash $51 Billion in New Wealth (Ad)In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. 7/31/202015,000 shares $172,500.00 +167.9%0.2%0 $11.50 7/15/20205,600 shares $52,584.00 -87.6%0.1%0 $9.39 6/30/202045,200 shares $405,896.00 +250.4%0.5%0.1 $8.98 6/15/202012,900 shares $48,117.00 +104.8%0.2%0 $3.73 5/29/20206,300 shares $22,806.00 -27.6%0.1%0.3 $3.62 5/15/20208,700 shares $26,535.00 +58.2%0.1%0.5 $3.05 4/30/20205,500 shares $16,225.00 -33.7%0.1%0.3 $2.95 4/15/20208,300 shares $26,560.00 No Change0.1%0.5 $3.20 3/31/20208,300 shares $27,390.00 +88.6%0.1%0.4 $3.30 3/13/20204,400 shares $12,804.00 -56.0%0.1%0.3 $2.91 2/28/202010,000 shares $22,000.00 +66.7%0.1%0.6 $2.20 2/14/20206,000 shares $18,000.00 -40.6%0.1%0.3 $3.00 1/31/202010,100 shares $32,320.00 -57.4%0.1%0.6 $3.20 1/15/202023,700 shares $71,100.00 +20.9%0.3%1.1 $3.00 12/31/201919,600 shares $64,288.00 +3.2%0.2%0.8 $3.28 ALPN Short Interest - Frequently Asked Questions What is Alpine Immune Sciences' current short interest? Short interest is the volume of Alpine Immune Sciences shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 3,890,000 shares of ALPN short. Learn More on Alpine Immune Sciences' current short interest. What is a good short interest ratio for Alpine Immune Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALPN shares currently have a short interest ratio of 2.0. Learn More on Alpine Immune Sciences's short interest ratio. Which institutional investors are shorting Alpine Immune Sciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Alpine Immune Sciences: Jane Street Group LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Alpine Immune Sciences' short interest increasing or decreasing? Alpine Immune Sciences saw a decrease in short interest in April. As of April 30th, there was short interest totaling 3,890,000 shares, a decrease of 17.9% from the previous total of 4,740,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Alpine Immune Sciences' short interest compare to its competitors? Here is how the short interest of companies compare to Alpine Immune Sciences: Xencor, Inc. (10.17%), Harpoon Therapeutics, Inc. (4.31%), MacroGenics, Inc. (15.21%), Assembly Biosciences, Inc. (0.58%), Royalty Pharma plc (3.47%), BeiGene, Ltd. (1.75%), BioMarin Pharmaceutical Inc. (1.97%), Viatris Inc. (3.61%), United Therapeutics Co. (9.14%), Dr. Reddy's Laboratories Limited (0.58%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Alpine Immune Sciences stock? Short selling ALPN is an investing strategy that aims to generate trading profit from Alpine Immune Sciences as its price is falling. ALPN shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Alpine Immune Sciences? A short squeeze for Alpine Immune Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ALPN, which in turn drives the price of the stock up even further. How often is Alpine Immune Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALPN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: XNCR Short Interest Data HARP Short Interest Data MGNX Short Interest Data ASMB Short Interest Data RPRX Short Interest Data BGNE Short Interest Data BMRN Short Interest Data VTRS Short Interest Data UTHR Short Interest Data RDY Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALPN) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpine Immune Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.